In a recent study published in The Lancet – the Pharmacogenomic Testing for Preventing Adverse Drug Reactions (PREPARE) study – […]
Croatia has grown into a thriving nation imbued with a rich cultural background and history. With its famous cities, stunning […]
According to new research from the University of East Anglia in collaboration with Boots UK and Leiden University, four million […]
Since the outbreak of the COVID-19 pandemic, many clinical trials have been launched to help understand the virus and any […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
Professor of Bioinformatics, Director, the Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London Co-Investigator, Health […]
Chris has studied cancer genetics for the best part of ten years. Previously he studied the genetics and pharmacogenetics of […]
Andrea Jorgensen is a Professor of Biostatistics at the University of Liverpool. She obtained an MSc with distinction in Medical […]
Dr Gemma Chandratillake is the Education and Training Lead for the East Midlands and East of England NHS Genomic Laboratory Hub.
